Ferrer

Ferrer is a leading international privately-held pharmaceutical company headquartered in Barcelona, Spain. Founded in 1959, the company has evolved from a traditional pharmaceutical manufacturer into a specialty pharma player with a strong focus on two main therapeutic pillars: neurological disorders (such as ALS and Progressive Supranuclear Palsy) and pulmonary vascular/interstitial lung diseases. The company is vertically integrated, spanning R&D, manufacturing of active pharmaceutical ingredients (APIs) through its Interquim brand, and global commercialization in over 110 countries. In recent years, Ferrer has distinguished itself through a purpose-driven business model, becoming a certified B Corp in 2022. It is currently recognized as the highest-scoring pharmaceutical company globally for social and environmental impact. The company reinvests a significant portion of its profits into social justice and environmental initiatives, prioritizing long-term sustainability and patient impact over short-term shareholder returns. Its strategic transformation under current leadership focuses on 'incremental innovation' and specialized medicines for severe, debilitating diseases with high unmet needs.